Navigation Links
NanoBio Expands Drug Development Team for Its Anti-Infective Products
Date:9/25/2007

ANN ARBOR, Mich., Sept. 25 /PRNewswire/ -- NanoBio(R) Corporation, a biopharmaceutical company developing novel anti-infective topicals and mucosal vaccines to treat and prevent serious infections, today announced the addition of four new scientists to its drug development team.

Lyou-fu Ma, PharmD, Ph.D.; Susan Ciotti, Ph.D.; Robert L. Hagan, Ph.D. and Paula L. Robinson will guide NanoBio in developing and commercializing its novel topical anti-infectives and mucosal vaccines. NanoBio's lead products are topical anti-infective lotions to eradicate cold sores and nail fungus, while its mucosal vaccines are in various stages of preclinical and human testing.

Dr. Ma has assumed the position of senior vice president of development and regulatory affairs, while Dr. Ciotti is the new director of formulation research and development at NanoBio Corporation. Dr. Hagan will serve as the senior manager of supply chain and Ms. Robinson will assume the position of clinical project manager.

"Each of our new scientific team members has a rich and diverse background in the pharmaceutical industry that will ensure our company's success as we accelerate our drug development programs," said James R. Baker, Jr., NanoBio's founder and chief science officer. "Their experience in taking compounds from preclinical testing through development will be invaluable in testing and developing our current and future products."

NanoBio's clinical programs for herpes labialis (cold sores) and onychomycosis (nail fungus) treatment have already yielded promising results, with clinical trials having demonstrated unparalleled safety and tolerability, added Baker. The collective experience of Ma, Ciotti, Hagan and Robinson will further expand the company's rich pipeline of products, he said.

Dr. Ma has 17 years of experience in the pharmaceutical industry. Prior to joining NanoBio, she served as development team leader in the pain therapy area at Pfizer Global Researc
'/>"/>

SOURCE NanoBio Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. WARF expands license agreement with Advanced Cell Technology
2. Verizon expands broadband service in Wisconsin
3. Bandwidth provider expands in Milwaukee
4. Wisconsins biodiesel network expands
5. Quad/Graphics expands reach in western states
6. University of South Florida expands GE Healthcare relationship
7. Metavante expands healthcare payments division
8. Fiserv expands services to health plan market
9. Bone Care expands patent protection of core drug offering
10. SBC and AT&T merger expands global reach for Wisconsin businesses
11. Expetec expands IT staff services in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...of Financial Executives International , a 15,000-...emics, and audit committee members, has announced ...community influence. , ,The group offers an opport...about the ethics, highest standards, and best prac...t the business dynamics of the Madison area are di...
...ates Air Force contract to fund the development of...vide a Madison aerospace research and product deve...ld enable it to propel something much larger. , ,T...d $3.9 million to Orbital Technologies Corp. (Or...le, but it might issue additional delivery orders ...
...mn by Geoff Bastow , will dissect topics that i... community, including: entrepreneurship in IT, in...nd technology trends that are driving real busine...kee, Wis. - At the dawn of the dot-com era and t...March of 2000, Kenosha entrepreneur John Weiss was...
...classified contract from the defense sector, Plex...ered here, reported record revenues and earnings f...spite the closing of its manufacturing facility in...mpered, however, by forecasts of lower-than-expect...s stock price to fall by roughly one-third. , ,Rev...
Other Biology Technology:Orbitec will use $25 million Air Force contract to make small launch vehicle 2Leadership insights from co-founder of Yesmail 2Leadership insights from co-founder of Yesmail 3Leadership insights from co-founder of Yesmail 4Leadership insights from co-founder of Yesmail 5Defense contract helps Plexus gain record profits 2
(Date:7/24/2008)...s could talk, they might tell potential suitors, "...lltale come slither look. But worms send their val... chemical code researchers are now cracking, accor...he journal Nature . , Scientists from the Univ...nia Institute of Technology and the U.S. Departmen...
(Date:7/24/2008)... typhoon in Taiwan buries as much carbon in the oc... rains in that country all year long combined. ,...tudy published in a recent issue of the journal G...e the chemistry of stream water and sediments that...happening at full force -- will help scientists de...
(Date:7/23/2008)...tions willing to collectively spend about $1 billi...half a billion metric tons of carbon dioxide per y... , It would take about that much money to put an...he world, one of the top contributors to greenhous...ted, this type of program could have potential to ...
(Date:7/23/2008)... Institute of Standards and Technology (NIST) have... clumps of proteins in protein-based pharmaceutica...ditions under which scientists can be assured that...rmation of protein aggregates, a major concern bec...n biologic drug manufacturing. , Proteins, a mai...
Breaking Biology News(10 mins):Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4NIST trumps the clumps: Making biologic drugs safer 2BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 1BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 2BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 3Melanoma of the rectum 3A A rare entity 18032 1Determined a new method to establish the antioxidant capacity of extra virgin olive oil 18029 1Determined a new method to establish the antioxidant capacity of extra virgin olive oil 18029 2Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 1Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 2Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 3
...nt form of good cholesterol provides significantly... than therapy using the "normal" HDL gene, accordi...chers at Cedars-Sinai Medical Center and reported ... College of Cardiology. , Apolipoprotein A-I is a...-density lipoprotein), the "good" cholesterol that...
...here there is a serious influenza outbreak will do...according to the findings of a study conducted at ...he journal PLoS Medicine. , Sometimes a new type ...hat is more serious than is usually the case for f...u pandemic killed between 20 million and 100 milli...
...f the human genome project, researchers at Dana-Fa... the Broad Institute of Harvard and MIT, and other...atic approach to drug discovery that matches disea...nguage based on cells, distinctive gene activity p...les being published in the September 29 issue of S...
...we hate. And yet, our "taste" for certain flavors ... we get tired of eating the same old thing. , Now...dence about what,s going on in the brain when we t...mething we once hated. , And although the study ...tions for understanding the way we perceive pleasu...
Other Biology News:Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 2Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 3Air travel and pandemic flu 2Scientists use gene signatures to match cancer and other diseases with potentially effective drugs 2Scientists use gene signatures to match cancer and other diseases with potentially effective drugs 3Tastes great! Study shows brain's response to pleasing -- and changing -- tastes 2Tastes great! Study shows brain's response to pleasing -- and changing -- tastes 3
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C
Request Info
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture.
Biology Products: